Skip to main content
MESO logo

Mesoblast Limited

MESONASDAQHealthcareBiotechnology

$13.18Today:- (-)1Y −26.61%

As of Oct 27, 2026 close

Market cap
$1.71B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$11.89$21.50
Volume (live)
-
Avg. volume (3M)
261.39K

Mesoblast (MESO) Financial Ratios

For fiscal 2026 (fiscal year ended Jun 30, 2026), Mesoblast had return on equity of -9.9% (up from -18.9%), debt-to-equity of 0.22 (up from 0.21), a current ratio of 2.44 (up from 1.99) and return on assets of -4.1% (up from -5.4%). A current ratio of 2.44 means current assets exceed current liabilities.

Mesoblast Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income StatementBalance SheetCash FlowRatios
Scroll to see more
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Period endingJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Valuation Ratios
P/S Ratio14.5780.58127.7281.9426.75130.39
P/B Ratio3.082.321.571.230.551.67
Price/Tangible Book861.2554.10---1063.66
Enterprise Value Ratios
EV/Revenue14.6286.01135.0990.6529.26126.17
Profitability & Returns
Return on Equity (ROE)-9.86%-18.95%-17.91%-16.40%-16.94%-17.48%
Return on Assets (ROA)-4.11%-5.37%-5.42%-6.50%-7.16%-11.93%
Return on Invested Capital (ROIC)------16.49%
Return on Capital Employed (ROCE)-7.40%-9.20%-9.70%-11.00%-13.20%-13.74%
Leverage & Solvency Ratios
Debt/Equity0.220.210.250.230.210.09
Liquidity Ratios
Current Ratio2.441.991.181.951.361.57
Quick Ratio1.981.721.141.851.251.50
Efficiency Ratios
Asset Turnover0.150.020.010.010.010.01
Inventory Turnover0.95-----
Yield & Distribution Ratios
Earnings Yield-3.28%-7.37%-11.67%-13.32%-33.44%-
FCF Yield-2.55%-3.65%-6.46%-10.34%-24.14%-
Buyback Yield-7.21%-22.41%-26.87%-13.89%-12.86%-14.42%
Total Return------14.42%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Mesoblast Financial Ratios

What is Mesoblast's return on equity?

Mesoblast's return on equity (ROE) was -9.9% for fiscal 2026 (period ended Jun 30, 2026). It was -18.9% a year earlier.

What is Mesoblast's debt-to-equity ratio?

Mesoblast's debt-to-equity ratio was 0.22 for fiscal 2026 (period ended Jun 30, 2026). It was 0.21 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition